All News

In case you missed it, this week we had news about e-cigarette task forces, combination COVID-19–flu vaccines, updating education on LGBT pain management, and more.

Emily Bellan, PharmD candidate at Duquesne University, shares insights on pharmacy school applications, on-campus involvement opportunities, and career paths after graduation.

Although a recent study revealed shortcomings associated with ChatGPT and its guidance on medication use, it doesn’t rule out its potential as a valuable health care tool.

Academic, corporate, and clinical institutions must empower pharmacists to deliver informed and compassionate care to LGBTQ individuals that matches the standard received by their heterosexual and cisgender peers.

In abstracts presented at the 2024 American Society of Clinical Oncology’s annual meeting, researchers addressed the association between heart failure and multiple types of cancers.

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

The therapy from AstraZeneca is indicated to improve glycemic control in patients aged 10 years or older.

The Supreme Court ruled on the question of limiting access to to mifepristone, a key abortion drug that anti-abortion groups have been working to limit across the country.

The APhA urged policy makers to consider these recommendations to avoid further exacerbating effects of the attack on US health systems.

Patients with advanced cancer can experience malignant wounds, which can have a negative impact on quality of life.

CDC researchers reported on the improvements and inaccuracies of assays within the Vitamin D Standardization-Certification Program.

As the opioid crisis and injection drug use continue, pharmacists can look to previous outbreaks to guide their responses to the HIV–injection drug use syndemic.

The Lingo and Libre Rio from Abbott are based on the company’s FreeStyle Libre sensing technology.

The new task force highlights a stronger government focus on curbing the risks of e-cigarettes for young people, especially after sustained calls for stricter action on the public health issue by lawmakers and the public.

In a study presented at ASCO 2024, investigators found that all 20 included patients with early stage breast cancer receiving chemotherapy developed hyperglycemia.

“The more we share our experiences and stories and work together as a profession, the more we can come together to support each other and form solutions,” said Joanna Lewis, PharmD, MBA, wellness writer and advocate, on overcoming burnout in the pharmacy.

Check out important updates from the FDA for the week of June 3.

In a session presented at the 2024 Heart in Diabetes Conference, researchers discussed the abilities of continuous glucose monitoring (CGM) to capture lifestyle data and improve mortality rates.

Vaccinated men and women are at a reduced risk for HPV-related cancers, according to research presented at ASCO 2024.

In an abstract presented at ENDO 2024, researchers addressed practitioners’ current knowledge of CGM and their experience prescribing in low-income communities.

HbA1c levels decreased significantly after an average of 154 days in patients who used a continuous glucose monitor.

The Psychopharmacologic Drugs Advisory Committee voted 10-1 that the benefits of MDMA do not outweigh its potential risks.

Posters presented at ENDO 2024 investigated excessive weight gain in breast cancer survivors and how high insulin levels impact outcomes for Black women with an aggressive form of the disease.

In an abstract presented at the Endocrine Society’s ENDO 2024 annual meeting in Boston, Massachusetts, researchers addressed the association between social vulnerability and glycemic control in patients with diabetes.

Research presented at ENDO 2024 found that glucagon-like peptide-1 receptor agonists had a lower acute pancreatitis recurrence risk than SGLT2i, DPP4i, and no medication.

In an abstract presented at the Endocrine Society’s ENDO 2024 annual meeting in Boston, Massachusetts, researchers explored access to GLP-1s for teenagers with and without type 2 diabetes.

While elevated BMI at baseline was not associated with increased cardiovascular risk, cumulative excess BMI was associated with an increased risk in people under 50.

Higher serum testosterone concentration was not associated with a reduced risk of developing type 2 diabetes in men older than 65.